GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc 6017 Snell Ave, Ste 357, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, email@example.com
#CHRT-65A anti_Dog Heartworm
Product name : anti_Dog Heartworm
Catalog number : CHRT-65A
Quantity: 1.0 mg
Supplier name : ICL
Data sheet: Ask more or other datasheet now !
More Details about
Chickens were immunized with extracts from both male and female heartworms. Eggs were collected and an IgY fraction was prepared. The resulting fraction was passed over an antigen containing immunoabsorbant from which the anti-canine heartworm antibodies were immunoaffinity purified.
For research use only, not for diagnostic or therapeutic use.
Contact us about this product :
Our team will respond you as soon as possible !
52062 Aachen Deutschland
Support Karolina Elandt
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
firstname.lastname@example.org | Gentaur
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Finland Helsset +358942419041
Magyarország Budapest +3619980547
US New York+17185132983
No related Items
Related Genes :
[BCL2] Apoptosis regulator Bcl-2
[MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A] Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 18.104.22.168) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a)
[TP53 P53] Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53)
[CTNNB1] Catenin beta-1 (Beta-catenin)
[TP53 P53] Cellular tumor antigen p53 (Tumor suppressor p53)
[MAPK14 CSBP1 CSBP2] Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 22.214.171.124) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha)
[ANO1 DOG1 ORAOV2 TAOS2 TMEM16A] Anoctamin-1 (Discovered on gastrointestinal stromal tumors protein 1) (Oral cancer overexpressed protein 2) (Transmembrane protein 16A) (Tumor-amplified and overexpressed sequence 2)
[BCL2] Apoptosis regulator Bcl-2
[rseA mclA yfiJ b2572 JW2556] Anti-sigma-E factor RseA (Regulator of SigE) (Sigma-E anti-sigma factor RseA) (Sigma-E factor negative regulatory protein)
[BIRC5] Baculoviral IAP repeat-containing protein 5 (Apoptosis inhibitor survivin)
[rsrA SCO5217] Anti-sigma factor RsrA (Regulator of SigR) (Sigma-R anti-sigma factor RsrA)
[PODXL PCLP PCLP1] Podocalyxin (Gp135) (Podocalyxin-like protein 1) (PC) (PC-like protein 1) (PCLP-1) (cPCLP1)
[BCAR1 CAS CASS1 CRKAS] Breast cancer anti-estrogen resistance protein 1 (CRK-associated substrate) (Cas scaffolding protein family member 1) (p130cas)
[DOG2 YHR043C] 2-deoxyglucose-6-phosphate phosphatase 2 (2-DOG-6-P 2) (2-deoxyglucose-6-phosphatase 2) (EC 126.96.36.199)
[DOG1 YHR044C] 2-deoxyglucose-6-phosphate phosphatase 1 (2-DOG-6-P 1) (2-deoxyglucose-6-phosphatase 1) (EC 188.8.131.52)
[PTGS1 COX1] Prostaglandin G/H synthase 1 (EC 184.108.40.206) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1)
[SHH] Hedgehog protein
[Bcl2 Bcl-2] Apoptosis regulator Bcl-2
[WNT5A] Protein Wnt
[AMHR2] Anti-Muellerian hormone type-2 receptor (EC 220.127.116.11) (Anti-Muellerian hormone type II receptor) (MIS type II receptor)
[CAV1 CAV] Caveolin-1 (Vesicular integral-membrane protein VIP21)
[PRKCD] Protein kinase C delta type (EC 18.104.22.168) (Tyrosine-protein kinase PRKCD) (EC 22.214.171.124) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)]
[AMHR2 AMHR MISR2] Anti-Muellerian hormone type-2 receptor (EC 126.96.36.199) (Anti-Muellerian hormone type II receptor) (AMH type II receptor) (MIS type II receptor) (MISRII) (MRII)
[BMP4] Uncharacterized protein
[BCL2L11] Bcl-2-like protein 11 (Bcl2-L-11) (Bcl2-interacting mediator of cell death)
[GATA3] Uncharacterized protein
[PTEN MMAC1] Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 188.8.131.52) (EC 184.108.40.206) (EC 220.127.116.11) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[NOTCH1] Uncharacterized protein
[ASF1 CIA1 YJL115W J0755] Histone chaperone ASF1 (Anti-silencing function protein 1) (yASF1)
 Structure and antigenicity analysis of the IgG gene for Nyctereutes procyonoides.
 A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management.
 Lack of correlation between mucosal immunoglobulin A-positive plasma cell numbers and TLR5 genotypes in German shepherd dogs with idiopathic chronic enteropathy.
 Genetic and antigenic analysis of mink's immunoglobulin G Fc region.
 Inhibitory effect of interferon gamma on frequency of Ehrlichia canis-infected cells in vitro.
 Characterization of canine filaggrin: gene structure and protein expression in dog skin.
 Surfactant protein-A concentration in sera from dogs with pulmonary parenchymal diseases.
 Evaluation of a microsphere-based immunofluorescence assay for the determination of Immunoglobulin A concentrations in cerebrospinal fluid of dogs.
 In vitro assessment of the allergenicity of novel MF59-adjuvanted pandemic H1N1 influenza vaccine produced in dog kidney cells.
 A simplified immune suppression scheme leads to persistent micro-dystrophin expression in Duchenne muscular dystrophy dogs.
Enter catalog number :